• Search
  • Advanced Search

Review

March 9, 2023


Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Clin Mol Hepatol. 2023;29(4):851-868.

The current requirement for biomarkers to detect hepatitis B virus (HBV) infection is polarized. One is a fully-automated and highly sensitive measurement system; the other is a simple system for...

Review

March 14, 2023


Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(4):869-890.

Nucleos(t)ide analogues (NA) are widely used to treat hepatitis B virus (HBV) infection, but they cannot eradicate the virus and treatment duration can be lifelong if the endpoint is set...

Review

April 13, 2023


Hepatorenal syndrome: Current concepts and future perspectives
Chan-Young Jung, Jai Won Chang
Clin Mol Hepatol. 2023;29(4):891-908.

Hepatorenal syndrome (HRS), a progressive but potentially reversible deterioration of kidney function, remains a major complication in patients with advanced cirrhosis, often leading to death before liver transplantation (LT). Recent...

Review

May 25, 2023


The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
Landon L. Chan, Stephen L. Chan
Clin Mol Hepatol. 2023;29(4):909-923.
Emergence of multi-targeted kinase inhibitors (MTIs) and immune checkpoint inhibitors (ICI) have changed the landscape of management in hepatocellular carcinoma (HCC). Combination therapy involving ICI has superseded sorafenib as the...

Review

June 5, 2023


Evidence-based hyponatremia management in liver disease
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Clin Mol Hepatol. 2023;29(4):924-944.

Hyponatremia is primarily a water balance disorder associated with high morbidity and mortality. The pathophysiological mechanisms behind hyponatremia are multifactorial, and diagnosing and treating this disorder remains challenging. In this...

Review

August 14, 2023


Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
Hwa Kyung Byun, Changhwan Kim, Jinsil Seong
Clin Mol Hepatol. 2023;29(4):945-957.

Hepatocellular carcinoma (HCC) is a highly lethal cancer with limited treatment options and poor prognosis. Carbon ion radiotherapy (CIRT) has emerged as a promising treatment modality for HCC due to...

Review

August 29, 2023


Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
Sung Uk Lee, Tae Hyun Kim
Clin Mol Hepatol. 2023;29(4):958-968.
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external beam radiation therapy has emerged as a promising approach for managing HCC. Proton beam therapy (PBT) offers dosimetric...

Original Article

July 5, 2023


Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, et al.
Clin Mol Hepatol. 2023;29(4):987-1001.

Background/Aims: To investigate whether non-alcoholic fatty liver disease (NAFLD) in individuals without generalized obesity is associated with visceral fat obesity (VFO), sarcopenia, and/or myosteatosis. Methods: This cross-sectional analysis included 14,400 individuals...

Original Article

September 11, 2023


Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study
Vy H. Nguyen, Isaac Le, Audrey Ha, et al.
Clin Mol Hepatol. 2023;29(4):1002-1012.

Background/Aims: Understanding of nonalcoholic fatty liver disease (NAFLD) continues to expand, but the relationship between race and ethnicity and NAFLD outside the use of cross-sectional data is lacking. Using longitudinal...

Original Article

July 5, 2023


Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
Ha Il Kim, Jihyun An, Seungbong Han, et al.
Clin Mol Hepatol. 2023;29(4):1013-1028.

Background/Aims: There is no clear consensus on the relative ranking of interventional and radiation techniques with indications similar to those of radiofrequency ablation (RFA) for the treatment of early hepatocellular...

Original Article

August 29, 2023


Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
Jeongin Yoo, Heejin Cho, Dong Ho Lee, et al.
Clin Mol Hepatol. 2023;29(4):1029-1042.

Background/Aims: The prediction of clinical outcomes in patients with chronic hepatitis B (CHB) is paramount for effective management. This study aimed to evaluate the prognostic value of computed tomography (CT)...
Current Issue
Volume 29(4); Oct 2023

This archive contains links to the full-text of all issues of Clin Mol Hepatol.

Current issue

Volume 29(4); October

All issues

Vol. 29
2023

v.29(1)
Jan 2023

v.29(Suppl)
Feb 2023

v.29(2)
Apr 2023

v.29(3)
Jul 2023

v.29(4)
Oct 2023
Vol. 28
2022

v.28(1)
Jan 2022

v.28(2)
Apr 2022

v.28(3)
Jul 2022

v.28(4)
Oct 2022
Vol. 27
2021

v.27(1)
Jan 2021

v.27(2)
Apr 2021

v.27(3)
Jul 2021

v.27(4)
Oct 2021
Vol. 26
2020

v.26(1)
Jan 2020

v.26(2)
Apr 2020

v.26(3)
Jul 2020

v.26(4)
Oct 2020
Vol. 25
2019

v.25(1)
Mar 2019
v.25(2)
Jun 2019
v.25(3)
Sep 2019 		v.25(4)
Dec 2019
Vol. 24
2018

v.24(1)
Mar 2018
v.24(2)
Jun 2018
v.24(3)
Sep 2018
v.24(4)
Dec 2018
Vol. 23
2017

v.23(1)
Mar 2017
v.23(2)
Jun 2017
v.23(3)
Sep 2017
v.23(4)
Dec 2017
Vol. 22
2016

v.22(1)
Mar 2016
v.22(2)
Jun 2016
v.22(3)
Sep 2016
v.22(4)
Dec 2016
Vol. 21
2015

v.21(1)
Mar 2015
v.21(2)
Jun 2015
v.21(3)
Sep 2015
v.21(4)
Dec 2015
Vol. 20
2014

v.20(1)
Mar 2014
v.20(2)
Jun 2014
v.20(3)
Sep 2014
v.20(4)
Dec 2014
Vol. 19
2013

v.19(1)
Mar 2013
v.19(2)
Jun 2013
v.19(3)
Sep 2013
v.19(4)
Dec 2013
The Korean Journal of Hepatology1995 (Vol.1 No.1) to 2012 (Vol.18 No.1)
Vol. 18
2012

v.18(1)
Mar 2012
v.18(2)
Jun 2012
v.18(3)
Sep 2012
v.18(4)
Dec 2012
Vol. 17
2011
v.17(1)
Mar 2011 		v.17(2)
Jun 2011 		v.17(3)
Sep 2011 		v.17(4)
Dec 2011
Vol. 16
2010
v.16(1)
Mar 2010 		v.16(2)
Jun 2010 		v.16(3)
Sep 2010 		v.16(4)
Dec 2010
Vol. 15
2009
v.15(1)
Mar 2009 		v.15(2)
Jun 2009 		v.15(3)
Sep 2009 		v.15(4)
Dec 2009 		v.15(60)
Dec 2009
Vol. 14
2008
v.14(1)
Mar 2008 		v.14(2)
Jun 2008 		v.14(3)
Sep 2008 		v.14(4)
Dec 2008
Vol. 13
2007
v.13(1)
Mar 2007 		v.13(2)
Jun 2007 		v.13(3)
Sep 2007 		v.13(4)
Dec 2007
Vol. 12
2006
v.12(1)
Mar 2006 		v.12(2)
Jun 2006 		v.12(3)
Sep 2006 		v.12(4)
Dec 2006
Vol. 11
2005
v.11(1)
Mar 2005 		v.11(2)
Jun 2005 		v.11(3)
Sep 2005 		v.11(4)
Dec 2005
Vol. 10
2004
v.10(1)
Mar 2004 		v.10(2)
Jun 2004 		v.10(3)
Sep 2004 		v.10(4)
Dec 2004
Vol. 9
2003
v.9(1)
Mar 2003 		v.9(2)
Jun 2003 		v.9(3)
Sep 2003 		v.9(4)
Dec 2003
Vol. 8
2002
v.8(1)
Mar 2002 		v.8(2)
Jun 2002 		v.8(3)
Sep 2002 		v.8(4)
Dec 2002
Vol. 7
2001
v.7(1)
Mar 2001 		v.7(2)
Jun 2001 		v.7(3)
Sep 2001 		v.7(4)
Dec 2001
Vol. 6
2000
v.6(1)
Mar 2000 		v.6(2)
Jun 2000 		v.6(3)
Sep 2000 		v.6(4)
Dec 2000
Vol. 5
1999
v.5(1)
Mar 1999 		v.5(2)
Jun 1999 		v.5(3)
Sep 1999 		v.5(4)
Dec 1999
Vol. 4
1998
v.4(1)
Mar 1998 		v.4(2)
Jun 1998 		v.4(3)
Sep 1998 		v.4(4)
Dec 1998
Vol. 3
1997
v.3(1)
Mar 1997 		v.3(2)
Jun 1997 		v.3(3)
Sep 1997 		v.3(4)
Dec 1997
Vol. 2
1996
v.2(1)
Jun 1996 		v.2(2)
Dec 1996
Vol. 1
1995
v.1(1)
Jun 1995

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

ABOUT
BROWSE ARTICLES
CURRENT ISSUE
FOR CONTRIBUTORS
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1437
TOTAL : 1558234
Close layer